ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 33.9% according to Berenberg Bank.
CTEC.L
Berenberg Bank set a target price of 310 GBX for the company, which when compared to the ConvaTec Group PLC share price of 232 GBX at opening today (06/09/2024) indicates a potential upside of 33.9%. Trading has ranged between 195 (52 week low) and 295 (52 week high) with an average of 6,106,758 shares exchanging hands daily. The market capitalisation at the time of writing is £4,796,506,260.
Convatec Group Plc is a United Kingdom-based medical products and technologies company. The Company is engaged in the development, manufacture and sale of medical products, services, and technologies. It is focused on solutions for the management of chronic conditions. It markets and sells its solutions and services in four categories, such as Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Advanced Wound Care includes advanced dressings for the management of acute and chronic wounds resulting from ongoing conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. Ostomy Care includes devices, accessories, and personalized services for individuals with a stoma. Continence and Critical Care includes products and services for people with urinary continence issues related to spinal cord injuries and other causes. Infusion Care includes disposable infusion sets used in insulin pump therapy for people with diabetes.
ConvaTec Group PLC 33.9% potential upside indicated by Berenberg Bank
[shareaholic app="share_buttons" id_name="post_below_content"]
- Written by: Charlotte Edwards
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
ConvaTec Group plc (LON:CTEC) reports strong annual results with 7.2% organic revenue growth, margin expansion and new product launches.